EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Analysis of Cytotoxic Lymphocytes‐Mediated Tumour Killing Related Genes Reveals LDHA as a Novel Glioblastoma Therapeutic Target

Shaojie Yu iD, Xudong Li, Ji Wu, Minjie Wang, Zihan Gong, Baowen Zhang, Haojun Shi, Xuan Wang, Wei Xiang iD

Journal of Cellular and Molecular Medicine · 2026-02 · 30 (4)

DOI: 10.1111/jcmm.71054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 13.02.2026. Verfasst von Shaojie Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. Hauptthemen laut MEDLINE: Glioblastoma, T-Lymphocytes, Cytotoxic, Brain Neoplasms, L-Lactate Dehydrogenase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Foundation of Hubei Key Laboratory of Biological Targeted Therapy, National Outstanding Youth Science Fund Project of National Natural Science Foundation of China, Youth Science Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) features profound immunosuppression and metabolic reprogramming that undermine immunotherapy. We sought biomarkers that capture cytotoxic lymphocyte activity and nominate tractable targets. Using TCGA, we quantified NK/CD8+ T‐cell infiltration (CIBERSORTx), identified differentially expressed genes and derived a three‐gene prognostic index (CTLsTKPI: LDHA, TNIP1, PTPN2) via Cox and LASSO. Performance was assessed in REMBRANDT, CGGA325 and CGGA693, and CTLsTKPI was incorporated into a multivariable nomogram alongside clinical variables. We examined associations with immune checkpoints, tumour mutational burden and stemness, and performed functional studies of LDHA in GBM cells, CAR‐NK92 assays and an orthotopic mouse model. We detected 3195 DEGs versus normal brain; 119 tracked with cytotoxic infiltration. CTLsTKPI stratified survival in TCGA (AUCs 0.694/0.656/0.819 at 1/2/3 years) and validated across cohorts; the nomogram outperformed individual predictors (AUC 0.78). High CTLsTKPI aligned with checkpoint pathway activation, Treg/macrophage enrichment and reduced activated NK/CD8 + T cells. LDHA was the dominant adverse component, linked to glycolysis; its overexpression enhanced proliferation, migration and invasion, while lactate impaired CAR‐NK cytotoxicity. In vivo, LDHA inhibition (GNE‐140) synergised with PD‐1 blockade to reduce tumour burden and prolong survival. CTLsTKPI provides a clinically actionable biomarker, and LDHA represents a rational therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaT-Lymphocytes, CytotoxicBrain NeoplasmsL-Lactate DehydrogenaseHumansAnimalsMiceGene Expression Regulation, NeoplasticBiomarkers, TumorCell Line, TumorCD8-Positive T-LymphocytesPrognosis

Stichwörter der Autor:innen

LDHAcytotoxic lymphocyte‐mediated tumour killingglioblastomaimmunotherapyprognostic signature

Substanzen

L-Lactate DehydrogenaseBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
  • Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

ORCID-Profile: Shaojie Yu, Wei Xiang

Förderung

  • Open Foundation of Hubei Key Laboratory of Biological Targeted Therapy
  • National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
  • Youth Science Fund Project

Zitieren

APA

Yu, S., Li, X., Wu, J., Wang, M., Gong, Z., Zhang, B., Shi, H., Wang, X., & Xiang, W. (2026). Integrative Analysis of Cytotoxic Lymphocytes‐Mediated Tumour Killing Related Genes Reveals LDHA as a Novel Glioblastoma Therapeutic Target. Journal of Cellular and Molecular Medicine, 30(4). https://doi.org/10.1111/jcmm.71054

Vancouver

Yu S, Li X, Wu J, Wang M, Gong Z, Zhang B, et al. Integrative Analysis of Cytotoxic Lymphocytes‐Mediated Tumour Killing Related Genes Reveals LDHA as a Novel Glioblastoma Therapeutic Target. Journal of Cellular and Molecular Medicine. 2026;30(4). doi:10.1111/jcmm.71054

BibTeX
@article{Yu2026,
  author = {Yu, Shaojie and Li, Xudong and Wu, Ji and Wang, Minjie and Gong, Zihan and Zhang, Baowen and Shi, Haojun and Wang, Xuan and Xiang, Wei},
  title = {Integrative Analysis of Cytotoxic Lymphocytes‐Mediated Tumour Killing Related Genes Reveals LDHA as a Novel Glioblastoma Therapeutic Target},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {4},
  doi = {10.1111/jcmm.71054}
}
Kostenlos starten →